PRAX-114 Produces Robust Increases in EEG Beta Frequency Power, a Translational Biomarker of GABA-A Receptor Modulation, Without Dose-Limiting …
1. 请及时下载文件确认是否正确, 系统将在 2026-07-16 10:52:00 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
Z Hughes, S Raines, L Scott…
Biological …, 2021
biologicalpsychiatryjournal.com
Background PRAX-114 is a GABA-A receptor positive allosteric modulator (GABAA-R-PAM) neuroactive steroid which achieves preferential potentiation of extrasynaptic GABAAR compared to synaptic GABAAR. GABAAR-PAMs cause increases in EEG β-frequency band power. The effects of PRAX-114 on quantitative EEG (qEEG) were measured in rodents and healthy human volunteers. Methods The effects of PRAX-114 (0.3-10mg/kg ip) on rat qEEG were measured in male SD rats fitted with EEG leads connected to a telemetry device in a …
